5 Comments
 

Based on the most helpful WSO content, some top-tier early-stage biotech venture capital firms that are known for leading Series A deals and might be interested in first-in-class early stage oncology assets include:

  • Atlas Venture
  • Third Rock
  • 5AM Ventures
  • Flagship Pioneering
  • Orbimed
  • Versant Ventures
  • ARCH Venture Partners

These firms are akin to the MBB (McKinsey, Bain, BCG) or bulge bracket banks of the biotech VC world, often leading the pack in terms of investment in innovative and groundbreaking biotech startups. They are known for their deep scientific expertise and may be more inclined to invest in cutting-edge oncology research rather than more conservative medtech ventures.

Sources: Healthcare / Biotech Venture Capital?, Biotech finance: from IB to VC / HF to funded startup, Guide To Evaluate a Biotech Company, Guide To Evaluate a Biotech Company

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Dolore est fuga laudantium quia velit modi sit. Voluptate est qui nisi numquam eligendi est. Sequi id qui dolor quibusdam quia. Quod reprehenderit aut perspiciatis inventore. Qui non ducimus totam aspernatur rerum non quo accusamus.

Ipsam soluta praesentium atque vel cumque facere possimus. Voluptatem esse explicabo voluptas architecto. Ut sint sint molestias.

Ipsam dignissimos pariatur rem. Sit necessitatibus omnis reprehenderit repudiandae pariatur error fugiat.

Totam qui sint ea quaerat vel. Dolorem officiis ipsa ipsa magni. Modi amet sequi cum doloribus quis recusandae.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 08 97.8%
  • Goldman Sachs 02 97.3%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.4%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.4%
  • Goldman Sachs 01 97.8%
  • JPMorgan No 97.3%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (50) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (25) $178
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (75) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
DrApeman's picture
DrApeman
98.9
6
CompBanker's picture
CompBanker
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
dosk17's picture
dosk17
98.9
9
GameTheory's picture
GameTheory
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”